Genmab, Incyte team up to develop experimental colorectal cancer treatment (INCY:NASDAQ)
Genmab, Incyte team up to develop experimental colorectal cancer treatment (INCY:NASDAQ) Seeking Alpha
Онкология
🎗️Лента новостей
🎗️
Онкология
Roche says divarasib cut risk of death 44% in lung cancer trial
Roche says divarasib cut risk of death 44% in lung cancer trial Reuters
Онкология
Summit Therapeutics reports survival benefit for cancer drug in trial (SMMT:NASDAQ)
Summit Therapeutics reports survival benefit for cancer drug in trial (SMMT:NASDAQ) Seeking Alpha
🎗️
Онкология
AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds
AstraZeneca's stomach cancer drug extends overall survival, late-stage trial data finds Reuters
🎗️
Онкология
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside SciTechDaily
Онкология
Big Questions in Oncology at ESMO 2026: Who Decides the Future of Cancer Care?
Big Questions in Oncology at ESMO 2026: Who Decides the Future of Cancer Care? Oncodaily
Онкология
HARMONi-GI1 at ESMO 2026: Ivonescimab Plus Chemotherapy in Advanced Biliary Tract Cancer
HARMONi-GI1 at ESMO 2026: Ivonescimab Plus Chemotherapy in Advanced Biliary Tract Cancer Oncodaily
Онкология
Targeted Combination Improves Lung Cancer Survival: ESMO 2026
Targeted Combination Improves Lung Cancer Survival: ESMO 2026 EMJ
Онкология
Результаты испытаний вакцины против меланомы
Результаты испытаний вакцины против меланомы Vietnam.vn
Онкология
CLARITY-Gastric 01 at ESMO 2026: Sonesitatug Vedotin in CLDN18.2-Positive Gastroesophageal Cancer
CLARITY-Gastric 01 at ESMO 2026: Sonesitatug Vedotin in CLDN18.2-Positive Gastroesophageal Cancer Oncodaily
Онкология
Новые биомаркеры открывают больше возможностей для ранней диагностики рака печени.
Новые биомаркеры открывают больше возможностей для ранней диагностики рака печени. Vietnam.vn